Oncology: Bladder
Information
Continuing Medical Education
CME
Saturday, May 16
PD15-01: The Role of Frailty in Radical Cystectomy Outcomes: Does Surgical Approach or Diversion Type Make a Difference?
PD15-02: LONGITUDINAL CHANGES IN BODY COMPOSITION AFTER RADICAL CYSTECTOMY: ASSOCIATIONS WITH POSTOPERATIVE COMPLICATIONS AND ONCOLOGIC OUTCOMES FROM THE UNIVERSITY OF WASHINGTON BOUNCEBACK COHORT STUDY
PD15-03: Antibiotic Prophylaxis for UTI Prevention after Radical Cystectomy (A-PURC): Interim Analysis of a Non-Inferiority Randomized Controlled Trial
PD15-04: Ten for staging, Twenty for survival plateau and adjuvant chemotherapy association: Node-yield thresholds for standard PLND in radical cystectomy
PD15-06: Radical Cystectomy vs Trimodal Therapy for Non-Metastatic Bladder Cancer in the United States: Contemporary Trends of Practice Patterns, Perioperative/Health-care Costs and Progression-Free Survival Outcomes
PD15-07: Reproductive organ-sparing does not detrimentally impact quality of life or oncologic outcomes in women undergoing radical cystectomy
PD15-08: Differences in Postoperative Healthcare Utilization After Robotic and Open Radical Cystectomy: A NSQIP Analysis
PD15-09: Prognostic value of systemic inflammation indices in radical cystectomy: a comprehensive analysis of SII and NLR
PD15-10: Examining the impact of TGF-b activity on fibroblast infiltration and immune exclusion in muscle-invasive bladder cancer
PD15-11: AI-Based Analysis of Perivascular regions from H&E Predicts Survival in Muscle-Invasive Bladder Cancer
PD15-12: Preoperative Circulating Tumor DNA as a Predictor of Recurrence Following Radical Cystectomy for Bladder Cancer: Revisiting the Role of Clinical Stage in the Molecular Era
PD15-13: Evaluating the Effect of Prior Checkpoint Inhibitor Exposure on Outcomes with Enfortumab Vedotin and Pembrolizumab in First Line Metastatic Bladder Cancer: A Retrospective Cohort Study
PD15-14: The cost of active surveillance in muscle-invasive bladder cancer for clinical complete response to neoadjuvant systemic therapy
PD15-15: Ligand-receptor network analysis for repurposing drug response prediction in muscle-invasive bladder cancer
Registered attendees
Yakov Klugman
Medical StudentRoswell Park Comprehensive Cancer Center